Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5

Journal of Cell Biology

Volumn 162, Issue 2, 2003, Pages 173-183

  Ohtani, Naoko ^a   Brennan, Paul ^b   Gaubatz, Stefan ^c   Sanij, Elaine ^d   Hertzog, Paul ^d   Wolvetang, Ernst ^d   Ghysdael, Jacques ^e   Rowe, Martin ^b   Hara, Eiji ^a,f  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d MONASH UNIVERSITY   (Australia)

^e INSTITUT CURIE   (France)

^f UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Cdk; Cell cycle; Ets; Immortalization; Senescence

Indexed keywords

CELL RECEPTOR; CYCLIN DEPENDENT KINASE; EXPORTIN 1; LATENT MEMBRANE PROTEIN 1; ONCOPROTEIN; PROTEIN P16; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR E2F5; TRANSCRIPTION FACTOR ETS 2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL CYCLE; CELL IMMORTALIZATION; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DISSOCIATION; EPSTEIN BARR VIRUS; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SENESCENCE; TUMOR SUPPRESSOR GENE; VIRUS TRANSFORMATION;

ACTIVE TRANSPORT, CELL NUCLEUS; B-LYMPHOCYTES; CELL LINE; CELL LINE, TRANSFORMED; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYTOPLASM; DNA-BINDING PROTEINS; E2F4 TRANSCRIPTION FACTOR; E2F5 TRANSCRIPTION FACTOR; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; KARYOPHERINS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; TRANSFECTION; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 0043174021     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200302085     Document Type: Article

References (85)

1. Alcorta, D.A., Y. Xiong, D. Phelps, G. Hannon, D. Beach, and J.C. Barrett. 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence. Proc. Natl. Acad. Sci. USA. 93:13742-13747.
2. Betz, B.L., M.W. Strobeck, D.N. Reisman, E.S. Knudsen, and B.E. Weissman. 2002. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene. 21:5193-5203.
3. Boulukos, K.E., P. Pognonec, B. Rabault, A. Begue, and J. Ghysdael. 1989. Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro. Mol. Cell. Biol. 9:5718-5721.
4. Brookes, S., J. Rowe, M. Ruas, S. Llanos, P. A. Clark, M. Lomax, M.C. James, R. Vatcheva, S. Bates, K.H. Vousden, D. Parry, N. Gruis, N. Smit, W. Bergman, and G. Peters. 2002. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J. 21:2936-2945.
5. Brown, K.D., B.S. Hostager, and G.A. Bishop. 2001. Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and Epstein-Barr Virus oncoprotein latent membrane protein 1 (LMP1). J. Exp. Med. 193:943-954.
6. INK4a Mol. Cell. 6:737-742.
7. Campisi, J. 2001. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11:S27-S31.
8. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
9. Chen, C.R., Y. Kang, P.M. Siegel, and J. Massague. 2002. E2F4/5 and p107 Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell. 110:19-32.
10. Classon, M., and E. Harlow. 2002. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer. 2:910-917.
11. Cohen, J.L., F. Wang, and E. Kieff. 1991. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J. Virol. 65:2545-2554.
12. Dajee, M., M. Lazarov, J.Y. Zhang, T. Cal, C.L. Green, A.J. Russell, M.P. Marinkovich, S. Tao, Q. Lin, Y. Kubo, and P.A. Khavari. 2003. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature. 421:639-643.
13. Dellambra, E., O. Golisano, S. Bondanza, E. Siviero, P. Lacal, M. Molinari, S. D'Atri, and M. de Luca. 2000. Down regulation of 14-3-3σ prevents clonal evolution and leads to immortalization of primary human keratinocytes. J. Cell Biol. 149:1117-1129.
14. DePinho, R.A. 2000. The age of cancer. Nature. 408:248-254.
15. Dowson, C.W., G. Tramountanis, A.G. Eliopoulos, and L.S. Young. 2003. Epstein-Barr virus latent memebrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J. Biol. Chem. 278:3694-3704.
16. Drayton, S., and G. Peters. 2002. Immortalisation and transformation revisited. Curr. Opin. Genet. Dev. 12:98-104.
17. Ducret, C., S.M. Maira, A. Dierich, and B. Wasylyk. 1999. The Net repressor is regulated by nuclear export in response to anisomycin, UV, and heat shock. Mol. Cell. Biol. 19:7076-7087.
18. Eliopoulos, A.G., and L.S. Young. 2001. LMP1 structure and signal transduction. Semin. Cancer Biol. 11:435-444.
19. Farrell, P.J. 1995. Epstein-Barr virus immortalizing genes. Trends Microbiol. 3:105-109.
20. Fons, G., J.J. Garcia-Ramirez, C.K. Galang, and C.A. Hauser. 1998. Elevated expression of Ets2 or distinct proteins of Ets2 can reverse ras-mediated cellular transformation. J. Biol. Chem. 273:18871-18880.
21. Fornerod, M., M. Ohno, M. Yoshida, and I.W. Mattaj. 1997. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell. 90:1051-1060.
22. Fukuda, M., W. Kurosaki, K. Yanagihara, H. Kuratsune, and T. Sairenji. 2002. A mechanism in Epstein-Barr virus oncogenesis: inhibition of transforming growth factor-beta 1-mediated induction of MAPK/p21 by LMP1. Virology. 302:310-320.
23. Gaubatz, S., G.J. Lindeman, S. Ishida, L. Jakoi, J.R. Nevins, D.M. Livingston, and R.E. Rempel. 2000. E2F4 and E2F5 play an essential role in pocket protein mediated G1 control. Mol. Cell. 6:729-735.
24. Gaubatz, S., J.A. Lees, G.J. Lindeman, and D.M. Livingston. 2001. E2F4 is exported from the nucleus in a CRM1-dependent manner. Mol. Cell. Biol. 21:1384-1392.
25. Graves, B.J., and J.M. Petersen. 1998. Specificity within ets family of transcription factors. Adv. Cancer Res. 75:1-55.
26. Gulley, M.L., J.M. Nicholls, B.G. Schneider, M.B. Amin, J.Y. Ro, and J. Geradts. 1998. Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product. Am. J. Pathol. 152:865-869.
27. Hammerschmidt, W., and B. Sugden. 1989. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature. 340:393-397.
28. CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell. Biol. 16:859-867.
29. Hayflick, L., and P.S. Moorhead. 1961. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 25:585-621.
30. Hunter, T. 1997. Oncoprotein network. Cell. 88:333-346.
31. INK4a confer resistance to Ras and Ets induced senescence in human diploid fibroblasts. Mol. Cell. Biol. 22:8135-8143.
32. Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277:14355-14358.
33. Jacobs, J.J., K. Kieboom, S. Marino, R.A. DePinho, and M. van Lohuizen. 1999. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 397:164-168.
34. Jansen-Durr, P. 1996. How viral oncogenes make the cell cycle. Trends Genet. 12:270-275.
35. Kaye, K.M., K.M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA. 90:9150-9154.
36. Kilger, E., A. Kieser, M. Baumann, and W. Hammerschmidt. 1998. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17:1700-1709.
37. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396:84-88.
38. Ink4a confers susceptibility to metastatic melanoma in mice. Nature. 413:83-86.
39. Kudo, N., B. Wolff, T. Sekimoto, E.P. Schreiner, Y. Yoneda, M. Yanagida, S. Horinouchi, and M. Yoshida. 1998. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242:540-547.
40. La Cour, T., R. Gupta, K. Rapacki, K. Skriver, F.M. Poulsen, and S. Brunak. 2003. NESbase version 1.0: a database of nuclear export signals. Nucleic Acids Res. 31:393-396.
41. Lin, A.W., M. Barradas, J.C. Stone, L. van Aelst, M. Serrano, and S.W. Lowe. 1998. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12:3008-3019.
42. ARF without relocation of MDM2 to the nucleolus. Nat. Cell Biol. 3:445-452.
43. Lloyd, A.C. 2002. Limits to lifespan. Nat. Cell Biol. 4:E25-E27.
44. Lundberg, A.S., W.C. Hahn, P. Gupta, and R.A. Weinberg. 2000. Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12:705-709.
45. Lyden, D., A.Z. Young, D. Zagzag, W. Yan, W. Gerald, R. O'Reilly, B.L. Bader, R.O. Hynes, Y. Zhuang, K. Monova, and R. Benezra. 1999. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature. 401:670-677.
46. INK4b. Mol. Cell. Biol. 20:2915-2925.
47. McConnell, B.B., M. Starborg, S. Brookes, and G. Peters. 1998. Inhibition of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol. 8:351-354.
48. INK4a inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol. Cell. Biol. 19:1981-1989.
49. Muller, H., M.C. Moroni, E. Vigo, B.O. Petersen, J. Bartek, and K. Helin. 1997. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol. Cell. Biol. 17:5508-5520.
50. Nevins, J.R. 2001. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10:699-703.
51. INK4a expression during cellular senescence. Nature. 409:1067-1070.
52. Ortega, S., M. Malumbres, and M. Barbacid. 2002. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta. 1602:73-87.
53. INK4a expression. EMBO J. 19:2969-2979.
54. Rayman, J.B., Y. Takahashi, V.B. Indjeian, J.-H. Dannenberg, S. Catchpole, R.J. Watson, H. te Riele, and B.D. Dynlacht. 2002. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev. 16:933-947.
55. Ren, B., H. Cam, Y. Takahashi, T. Volkert, J. Terragni, R.A. Young, and B.D. Dynlacht. 2002. E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev. 16:245-256.
56. Roberts, M.L., and N.R. Cooper. 1998. Activation of Ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology. 240:93-99.
57. Rodier, G., A. Montagnoli, L. Di Marcotullio, P. Coulombe, G.F. Draetta, M. Pagano, and S. Meloche. 2001. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J. 20:6672-6682.
58. Roussel, M.F., R.A. Ashmun, C.J. Sherr, R.N. Eisenman, and D.E. Ayer. 1996. Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol. Cell. Biol. 16:2796-2801.
59. Sanij, E., B. Scott, T. Wilson, D. Xu, P. Hertzog, and E. Wolvetang. 2003. Characterization of monoclonal antibodies specific to the transcription factor Ets2 protein. Immunol. Lett. 86:63-70.
60. Schultheiss, U., S. Puschner, E. Kremmer, T.M. Mak, H. Engelman, W. Hammerschmidt, and A. Kieser. 2001. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. EMBO J. 20:5678-5691.
61. INK4b. Nat. Cell Biol. 3:400-408.
62. Serrano, M., and M.A. Blasco. 2001. Putting the stress on senescence. Curr. Opin. Cell Biol. 13:748-753.
63. INK4a. Cell. 88:593-602.
64. Atf predisposes mice to rumorigenesis. Nature. 413:86-91.
65. Sharrocks, A.D. 2001. The Ets-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2:827-837.
66. Sherr, C.J. 1996. Cancer cell cycles. Science. 274:1672-1677.
67. Sotillo, R., P. Dubus, J. Martin, E. de la Cueva, S. Ortega, M. Malumbres, and M. Barbacid. 2001. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J. 20:6637-6647.
68. Stade, K., C.S. Ford, C. Guthrie, and K. Weis. 1997. Exportin 1 (Crm1p) is an essential nuclear export factor. Cell. 90:1041-1050.
69. INK4b expression by Myc through association with Miz-1. Nat. Cell Biol. 3:392-399.
70. Stein, G.H., M. Beeson, and L. Gordon. 1990. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science. 249:666-669.
71. Stein, G.H., L.F. Drullinger, A. Soulard, and V. Dulic. 1999. Differential roles of cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19:2109-2117.
72. SEI-1. Genes Dev. 13:3027-3033.
73. Sun, Y., A. Hildesheim, A.E. Lanier, Y. Cao, K.T. Yao, N. Raab-Traub, and C.S. Yand. 1995. No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas. Oncogene. 10:785-788.
74. Thorley-Lawson, D.A. 2001. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol. 1:75-82.
75. Tomkinson, B., E. Robertson, and E. Kieff. 1993. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67:2014-2025.
76. Tomoda, K., Y. Kubota, and J. Kato. 1999. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab 1. Nature. 398:160-165.
77. Trimarchi, J.M., and J.A. Lees. 2002. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3:11-20.
78. Verona, R., K. Moberg, S. Estes, M. Starz, J.P. Vernon, and J.A. Lees. 1997. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol. Cell. Biol. 17:7268-7282.
79. Wang, D., D. Liebowitz, and E. Kieff. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 43:831-840.
80. Weinberg, R.A. 1997. The cat and mouse games that genes, viruses, and cells play. Cell. 88:573-575.
81. Wu, L., G. Timmers, B. Maiti, H.I. Saavedra, L. Sang, G.T. Chong, F. Nuckolls, P. Giangrande, F.A. Wright, S.J. Field, et al. 2001. The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 414:457-462.
82. Xin, B., Z. He, X. Yang, C.P. Chan, M.H. Ng, and L. Cao. 2001. TRADD domain of Epstein-Barr virus transforming protein LMP1 is essential for inducing immortalization and suppressing senescence of primary rodent fibroblasts. J. Virol. 75:3010-3015.
83. Yang, X., J.S.T. Sham, S.W. Tsao, D. Zhang, S.W. Lowe, and L. Cao. 2000a. LMP1 of Epstein-Barr virus induces proliferation of primary mouse embryonic fibroblasts and cooperatrively transforms the cells with a p16-insensitive CDK4 oncogene. J. Virol. 74:883-891.
84. INK4a expression. Oncogene. 19:2002-2013.
85. Zhu, J., D. Woods, M. McMahon, and J.M. Bishop. 1998. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:2997-3007.